Details checkedClinical trial listing onlyCheckedregistry

Institut Pasteur AUDIOGENAGE diagnostic battery study

Also known as: AUDIOGENAGE, Audiological and vestibular tests, Development of a Battery of Audiological Tests for Precision Diagnosis of Age-related Hearing Loss, NCT05312983

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Diagnostic

Modality

Diagnostic

Stage

Interventional/NA

Status

Active

Target Gene

—

Route / Mode

Audiological and vestibular test battery with blood sampling

Confidence

82%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-09

Geography

France

Population

adult, older-adult, age-related, genetic, healthy-volunteer

Trial IDs

Mechanism

Recruiting French diagnostic study developing a non-invasive audiological and vestibular test battery, with neurocognitive questionnaires and genetic sampling, to characterize early-onset age-related hearing loss and guide precision fitting.

Indications

Hearing Loss Sensorineural Hearing Loss Age-Related Hearing Loss

Notes

Normalized from a generic testing row into the active AUDIOGENAGE diagnostic study. ClinicalTrials.gov lists Institut Pasteur as the sponsor, but this should be treated in HearScape as institution-led research rather than a commercial company program.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, aliases, allCompanies, isIndustrySponsored, stage, status, route, indications...

IDs: NCT05312983

Open

Key Events

2022-07-28

AUDIOGENAGE diagnostic battery study started

2025-03-03

ClinicalTrials.gov posted latest recruiting update reviewed in this pass

Clinical Trials (1)